Cambridge, United Kingdom

Alex Eberlin

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Alex Eberlin

Introduction: Alex Eberlin, a prominent inventor based in Cambridge, GB, has made notable contributions to the field of pharmaceuticals, holding a remarkable portfolio of 17 patents. His inventive spirit and dedication to advancing medical science have placed him at the forefront of innovation, particularly in the development of cocrystals that have significant therapeutic potential.

Latest Patents: Eberlin's latest patents showcase his innovative work with cannabidiolic acid and olaparib. His patent on "Cannabidiolic acid cocrystals" presents compositions that include various cocrystals with L-phenylalanine, vanillin, betaine, ethyl maltol, and proline. These compositions, particularly when formulated as pharmaceutical compositions with a suitable carrier, have implications for treating a range of diseases and disorders. Additionally, his invention of "Olaparib hydroxybenzoic acid cocrystals" details new cocrystal formations that are crucial for targeting diseases through poly (ADP-ribose) polymerase (PARP) inhibition. These advancements open doors for innovative treatment methods in modern medicine.

Career Highlights: Throughout his career, Alex Eberlin has brought his inventive genius to various companies, notably Intercept Pharmaceuticals, Inc. and Radius Pharmaceuticals, Inc. His work within these organizations has significantly contributed to pharmaceutical research and development, leading to advancements in therapeutic applications that benefit patients worldwide.

Collaborations: Collaboration has been a key element in Eberlin's success. He has worked alongside talented professionals such as André Steiner and Heidi Waenerlund Poulsen, capitalizing on their expertise to push the boundaries of pharmaceutical innovations and develop groundbreaking solutions.

Conclusion: Alex Eberlin's inventive work has undoubtedly advanced the field of pharmaceuticals, particularly through his development of significant cocrystals. With a total of 17 patents to his name and his ongoing collaborations, Eberlin continues to inspire the next generation of innovators striving to improve healthcare and treatment options. His contributions are a testament to the power of innovation in addressing complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…